Companies
- Companies
- Company details
BioVex
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEXThe company in detail
Summary
Biovex was founded in February 1999 by Dr Robert Coffin (CSO) and Professor David Latchman (Dean of the Institute of Child Heath, UK) a CEO was appointed in the same year and in mid-2000 the board was expanded with the addition of two more directors. The company was granted a core patent by the US patent office, entered the first of several collaborations and also raised £10 million in a second round financing in 2001. In June 2005 relocated its headquarters from the UK to Cambridge, Massachusetts, USA.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 37 pages - $500
Nov 2010 - 88 pages - $600
Jul 2010 - 40 pages - $750
Feb 2011 - 34 pages - $500
Sep 2011 - 109 pages - $1,000
Dec 2010 - 73 pages - $1,000
Feb 2010 - 84 pages - $3,500
Oct 2010 - 64 pages - $2,000
Dec 2010 - 269 pages - $11,400
Sep 2011 - 49 pages - $500
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Gene therapy
- Biotechnology / Human therapeutics
- Biotechnology / Other
- Drug discovery
- Drug discovery / Genomics
- Drug discovery / High throughput screening
- Pharmaceutical / Prescription
- Research tools / Mouse models
- Research tools / Vectors
- Therapeutic target
- Central Nervous System
- Central Nervous System / CNS (other)
- Central Nervous System / Pain / Anesthesia
- Central Nervous System / Pain / Pain management general
- Central Nervous System / Neurological / Epilepsy
- Central Nervous System / Neurodegenerative disorders / Parkinson's disease
- Central Nervous System / Psychiatric / Mental health (other)
- Central Nervous System / Psychiatric / Depression
- Endocrinology
- Endocrinology / Hypothalamic
- Infectious diseases
- Infectious diseases / Diseases / Infection, viral (other)
- Infectious diseases / Treatments / Vaccine
- Infectious diseases / Bacteria or virus / Herpes simplex virus
- Oncology
- Oncology / Breast cancer
- Oncology / Head and neck cancer
- Oncology / Skin cancer
- Oncology / Tumor (other)
- Oncology / Treatments / Chemotherapy
- Oncology / Skin cancer / Melanoma
- Oncology / Stomach/Esophageal / Adenocarcinoma
- Other therapeutic
- Sensory organ
- Sensory organ / Opthalmic / Ophthalmic disorder (other)
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us